CV1808 (Standard)
CV1808 (Standard) is the analytical standard of CV1808. This product is intended for research and analytical applications. CV1808? (2-Phenylaminoadenosine) is a non-selective A2?adenosine receptor (A2 AR) agonist with Kis of 76 and 1450 nM for A2A and A3 adenosine receptor subtypes, respectively[1].
Product Specifications
CAS Number
53296-10-9
Product Name Alternative
2-Phenylaminoadenosine (Standard)
UNSPSC
12352005
Target
Adenosine Receptor; Endogenous Metabolite; Reference Standards
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease; Others
Field of Research
Inflammation/Immunology
Smiles
NC1=C2C(N([C@@]3([H])[C@@H]([C@@H]([C@H](O3)CO)O)O)C=N2)=NC(NC4=CC=CC=C4)=N1
Molecular Formula
C16H18N6O4
Molecular Weight
358.35
References & Citations
[1]K H Yip, et al. Reciprocal modulation of anti-IgE induced histamine release from human mast cells by A₁ and A (2B) adenosine receptors. Br J Pharmacol. 2011 Sep;164 (2b) :807-19. |[2]I van der Ploeg, et al.Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists. Naunyn Schmiedebergs Arch Pharmacol.1996 Feb;353 (3) :250-60. |[3]Ming-Guo Feng, et al. Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation. Am J Physiol Renal Physiol. 2010 Aug;299 (2) :F310-5.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
124715 100 µg
CD99 (CD99 Antigen, 12E7, E2 Antigen, Protein MIC2, T-cell Surface Glycoprotein E2, MIC2, MIC2X, MIC2Y)
Sign In for Pricing
View Details GTR15102870 1 Vial
Lentiviral human DYSF shRNA (UAS) - Lentiviral human DYSF shRNA (UAS) (100)
Sign In for Pricing
View Details 
TMPY-06062-01 5 µg
Influenza B (B/Phuket/3073/2013) Nucleoprotein/NP Protein (His)
Sign In for Pricing
View Details TMPY-06062-02 10 µg
Influenza B (B/Phuket/3073/2013) Nucleoprotein/NP Protein (His)
Sign In for Pricing
View Details